PMID- 15271798 OWN - NLM STAT- MEDLINE DCOM- 20041223 LR - 20220408 IS - 0006-4971 (Print) IS - 0006-4971 (Linking) VI - 104 IP - 10 DP - 2004 Nov 15 TI - The contribution of endothelial cell P-selectin to the microvascular flow of mouse sickle erythrocytes in vivo. PG - 3378-85 AB - Microvascular occlusion in sickle cell disease can be initiated by adhesion of sickle red blood cells (RBCs) to the endothelium. Our objective in this study was to verify the relevance in vivo of our discovery that sickle RBCs adhere abnormally to endothelial P-selectin in vitro. We used computer-assisted intravital microscopy to characterize RBC flow velocity (V(RBC)) in mice. We found faster V(RBC) of sickle RBCs in P-selectin knock-out and control mice than in sickle cell mice, which have increased endothelial cell P-selectin expression. Agonist peptide for murine protease-activated receptor-1 (PAR-1), which selectively activates mouse endothelial cells but not platelets, was used to assess the effects of endothelial cell P-selectin on microvascular flow. Suffusion of venules with this agonist stopped flow promptly in normal and sickle mice but not in P-selectin knock-out mice or in control mice pretreated with anti-P-selectin monoclonal antibody or unfractionated heparin (UFH). Agonist-induced slowing of flow was reversed rapidly by suffusion with UFH, provided flow had not already stopped. We conclude that endothelial cell P-selectin contributes to the microcirculatory abnormalities in sickle cell disease and that blocking P-selectin may be useful for preventing painful vasoocclusion in sickle cell disease. FAU - Embury, Stephen H AU - Embury SH AD - Department of Medicine, University of San Francisco, CA, USA. sembury@itsa.ucsf.edu. FAU - Matsui, Neil M AU - Matsui NM FAU - Ramanujam, Sahana AU - Ramanujam S FAU - Mayadas, Tanya N AU - Mayadas TN FAU - Noguchi, Constance T AU - Noguchi CT FAU - Diwan, Bhalchandra A AU - Diwan BA FAU - Mohandas, Narla AU - Mohandas N FAU - Cheung, Anthony T W AU - Cheung AT LA - eng GR - HL64396/HL/NHLBI NIH HHS/United States GR - HL67432/HL/NHLBI NIH HHS/United States GR - N01-CO-12400/CO/NCI NIH HHS/United States GR - HL20985/HL/NHLBI NIH HHS/United States GR - HL31579/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. DEP - 20040722 PL - United States TA - Blood JT - Blood JID - 7603509 RN - 0 (Antibodies, Monoclonal) RN - 0 (P-Selectin) RN - 0 (Receptor, PAR-1) RN - 9005-49-6 (Heparin) SB - IM MH - Anemia, Sickle Cell/*metabolism/*physiopathology MH - Animals MH - Antibodies, Monoclonal/pharmacology MH - Blood Flow Velocity MH - Cell Adhesion MH - Endothelium, Vascular/cytology/*metabolism MH - Erythrocytes/cytology/*physiology MH - Heparin/analogs & derivatives MH - Leukocytes/cytology MH - Mice MH - Mice, Inbred C57BL MH - Mice, Mutant Strains MH - Microcirculation MH - P-Selectin/immunology/*metabolism MH - Receptor, PAR-1/agonists/metabolism EDAT- 2004/07/24 05:00 MHDA- 2004/12/24 09:00 CRDT- 2004/07/24 05:00 PHST- 2004/07/24 05:00 [pubmed] PHST- 2004/12/24 09:00 [medline] PHST- 2004/07/24 05:00 [entrez] AID - S0006-4971(20)55904-1 [pii] AID - 10.1182/blood-2004-02-0713 [doi] PST - ppublish SO - Blood. 2004 Nov 15;104(10):3378-85. doi: 10.1182/blood-2004-02-0713. Epub 2004 Jul 22.